About the Authors
- Qiang Shi
-
Roles Conceptualization, Methodology, Project administration, Writing – review & editing
Affiliation Eli Lilly & Co., Shanghai, China
- Ko-Jen Li
-
Roles Conceptualization, Supervision, Writing – review & editing
Affiliation National Taiwan University, Taipei, Taiwan
- Tamas Treuer
-
Roles Conceptualization, Writing – review & editing
Affiliation Eli Lilly & Co., Budapest, Hungary
- Bruce C. M. Wang
-
Roles Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Supervision, Validation, Writing – original draft, Writing – review & editing
Affiliation Elysia Group Ltd., Taipei, Taiwan
- Carol L. Gaich
-
Roles Conceptualization, Methodology, Writing – review & editing
Affiliation Eli Lilly & Co., Indianapolis, Indiana, United States of America
- Chien-Hsun Lee
-
Roles Conceptualization, Methodology, Writing – review & editing
Affiliation Eli Lilly & Co., Taipei, Taiwan
- Wen-Shuo Wu
-
Roles Conceptualization, Methodology, Writing – review & editing
Affiliation Eli Lilly & Co., Taipei, Taiwan
- Wesley Furnback
-
Roles Conceptualization, Data curation, Formal analysis, Methodology, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing
Affiliation Elysia Group Ltd., Taipei, Taiwan
- Chao-Hsiun Tang
-
Roles Conceptualization, Data curation, Formal analysis, Supervision, Writing – review & editing
* E-mail: chtang@tmu.edu.tw
Affiliation Taipei Medical University, Taipei, Taiwan
Competing Interests
The authors have read the journal's policy and have the following conflicts: QS is an employee of Eli Lilly and owns stock in Eli Lilly. KL is a paid consultant for Eli Lilly. TT is an employee of Eli Lilly and owns stock in Eli Lilly. BW is an employee of Elysia Group and a paid consultant for Eli Lilly. CG is an employee of Eli Lilly and owns stock in Eli Lilly. CL is an employee of Eli Lilly. WW is an employee of Eli Lilly and owns stock in Eli Lilly. WF is an employee of Elysia Group and a paid consultant to Eli Lilly. CT is a paid consultant for Eli Lilly. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.